#1 Clinical Trials Search in Europe

Diclofenac Epolamine

This article examines the use of diclofenac epolamine, a nonsteroidal anti-inflammatory drug (NSAID), in various clinical trials. The studies focus on its effectiveness in managing pain from conditions like ankle sprains, soft tissue injuries, and post-surgical discomfort. We’ll explore the drug’s application methods, safety profile, and potential benefits across different patient groups, including children and adults.

Table of Contents

What is Diclofenac Epolamine?

Diclofenac epolamine is a type of medication known as a nonsteroidal anti-inflammatory drug (NSAID). It’s used to relieve pain and reduce inflammation in various conditions. This drug is also known by several brand names, including Flector Patch, Licart, and Pennsaid[1][2][3].

Uses and Conditions Treated

Diclofenac epolamine is used to treat several conditions, including:

  • Acute pain due to minor ankle sprain: It helps reduce pain and inflammation associated with minor ankle injuries[1].
  • Soft tissue injuries: The medication is effective in treating pain from minor soft tissue injuries[2].
  • Acute back strain: It can be used to alleviate pain from sudden back injuries[4].
  • Athletic injuries: The drug is beneficial in managing pain from sports-related injuries[5].

Available Formulations

Diclofenac epolamine is available in several formulations:

  • Topical patch: This is a common form of the medication, often referred to as Flector Patch or Licart. The patch is applied directly to the skin over the affected area[1][2].
  • Topical solution: Known as Pennsaid, this liquid form is applied to the skin[3].
  • Intramuscular injection: In some cases, diclofenac may be given as an injection into a muscle[6].

How It Works

Diclofenac epolamine works by reducing the production of substances in the body that cause pain and inflammation. When applied to the skin, it penetrates into the underlying tissues to provide localized pain relief. This targeted approach helps minimize systemic exposure to the drug, potentially reducing the risk of side effects compared to oral NSAIDs[1][2].

Effectiveness

Clinical trials have shown that diclofenac epolamine is effective in reducing pain and improving function in various conditions:

  • In patients with minor ankle sprains, the medication provided significant pain relief compared to placebo[1].
  • For acute back strain, patients reported improved pain scores and overall satisfaction with the treatment[4].
  • In soft tissue injuries, the drug demonstrated effectiveness in reducing pain intensity and improving functional performance[2].

How It’s Administered

The administration of diclofenac epolamine depends on its formulation:

  • Topical patch: The patch is typically applied to the most painful area once or twice daily. It’s important to follow the instructions provided by your healthcare provider or on the product label[1][2].
  • Topical solution: The liquid is applied to the affected area, usually multiple times a day as directed by your doctor[3].
  • Intramuscular injection: This form is typically administered by a healthcare professional[6].

Safety and Side Effects

While diclofenac epolamine is generally well-tolerated, especially in its topical forms, it can cause side effects. Common side effects may include:

  • Skin reactions at the application site, such as redness, itching, or burning[2].
  • Gastrointestinal issues, particularly with oral or injectable forms[6].

It’s important to discuss any side effects with your healthcare provider. As with all NSAIDs, there are potential risks associated with long-term use or high doses, particularly for people with certain medical conditions.

Use in Special Populations

Research is ongoing to determine the safety and effectiveness of diclofenac epolamine in different populations:

  • Children: Studies are being conducted to evaluate the use of diclofenac epolamine in pediatric patients with soft tissue injuries[2].
  • Elderly: While not specifically studied, older adults may be more sensitive to side effects and should use the medication with caution.

Ongoing Research

Researchers continue to study diclofenac epolamine to better understand its effects and potential uses:

  • Investigating its use in breast cancer treatment by applying the medication to the skin of the breast[7].
  • Evaluating its effectiveness in preventing complications after certain medical procedures[6].
  • Studying patient preferences for different methods of pain relief and how this affects treatment outcomes[8].

As with any medication, it’s crucial to use diclofenac epolamine only as directed by your healthcare provider. They can provide personalized advice based on your specific medical history and current condition.

Aspect Details
Primary Uses Pain management for ankle sprains, soft tissue injuries, acute back strain, post-surgical pain
Administration Methods Topical patches, medicated plasters, topical solutions
Patient Groups Adults and children (some studies focus on ages 6-16)
Trial Durations Typically 3-14 days
Key Outcomes Measured Pain reduction (VAS scores), local tolerability, pharmacokinetics, safety profile
Potential Benefits Localized pain relief, potentially fewer systemic side effects than oral NSAIDs
Safety Considerations Monitoring for local skin reactions, systemic absorption, adverse events
Comparative Studies Some trials compare topical diclofenac epolamine to oral diclofenac or placebo

FAQ

  • What is diclofenac epolamine used for in clinical trials? Diclofenac epolamine is primarily used in clinical trials for pain management in conditions such as ankle sprains, soft tissue injuries, acute back strain, and post-surgical pain. It's being studied in various forms, including topical patches and medicated plasters.
  • How is diclofenac epolamine typically administered in these trials? In most trials, diclofenac epolamine is administered topically, often as a patch or medicated plaster applied directly to the affected area. Some studies use it as a topical solution or compare it to oral forms of diclofenac.
  • Are there any studies on the use of diclofenac epolamine in children? Yes, there are clinical trials investigating the safety and efficacy of diclofenac epolamine in pediatric patients. For example, one study is looking at its use in children aged 6-16 with minor soft tissue injuries.
  • What are some of the potential benefits of using diclofenac epolamine topically? Topical application of diclofenac epolamine may provide localized pain relief with potentially fewer systemic side effects compared to oral NSAIDs. Some studies are also investigating its ability to deliver uniform therapeutic concentrations throughout the treated area.
  • How long do most clinical trials involving diclofenac epolamine last? The duration of clinical trials varies, but many last between 3 to 14 days. Some studies assess short-term effects over a few days, while others monitor patients for up to two weeks to evaluate longer-term efficacy and safety.

Ongoing Clinical Trials on Diclofenac Epolamine

  • Study on Walking Rehabilitation for Hip or Knee Osteoarthritis Using Ketoprofen and Drug Combination for Patients with Osteoarthritis

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

Glossary

  • Diclofenac epolamine: A nonsteroidal anti-inflammatory drug (NSAID) used topically for pain relief, often in the form of patches or medicated plasters.
  • Topical system: A method of drug delivery where the medication is applied directly to the skin, often in the form of a patch, cream, or solution.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Visual Analogue Scale (VAS): A measurement tool used to assess pain intensity, typically using a scale from 0 (no pain) to 100 (worst pain imaginable).
  • Placebo: An inactive substance or treatment used in clinical trials to compare the effects of a drug against a control group.
  • Soft tissue injury: Damage to muscles, ligaments, or tendons, often caused by sprains, strains, or contusions.
  • Local tolerability: The degree to which a topical medication can be applied without causing irritation or discomfort at the application site.
  • Efficacy: The ability of a drug or treatment to produce the desired effect or outcome in clinical trials.
  • Adverse event: Any unfavorable or unintended sign, symptom, or disease that occurs during a clinical trial, whether or not it is related to the treatment being studied.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.

References

  1. https://clinicaltrials.gov/study/NCT02324270
  2. https://clinicaltrials.gov/study/NCT05171673
  3. https://clinicaltrials.gov/study/NCT01350622
  4. https://clinicaltrials.gov/study/NCT01054820
  5. https://clinicaltrials.gov/study/NCT02132247
  6. https://clinicaltrials.gov/study/NCT01946984
  7. https://clinicaltrials.gov/study/NCT01380353
  8. https://clinicaltrials.gov/study/NCT01263652